Cardiovascular Safety of Roxadustat in CKD Anemia: A Fig Leaf Named Noninferiority
- PMID: 34362784
- PMCID: PMC8455055
- DOI: 10.2215/CJN.08280621
Cardiovascular Safety of Roxadustat in CKD Anemia: A Fig Leaf Named Noninferiority
Keywords: anemia; cardiovascular.
Comment on
-
Efficacy and Cardiovascular Safety of Roxadustat for Treatment of Anemia in Patients with Non-Dialysis-Dependent CKD: Pooled Results of Three Randomized Clinical Trials.Clin J Am Soc Nephrol. 2021 Aug;16(8):1190-1200. doi: 10.2215/CJN.16191020. Clin J Am Soc Nephrol. 2021. PMID: 34362786 Free PMC article.
References
-
- Locatelli F, Fishbane S, Block GA, Macdougall IC: Targeting hypoxia-inducible factors for the treatment of anemia in chronic kidney disease patients. Am J Nephrol 45: 187–199, 2017 - PubMed
-
- Provenzano R, Szczech L, Leong R, Saikali KG, Zhong M, Lee TT, Little DJ, Houser MT, Frison L, Houghton J, Neff TB: Efficacy and cardiovascular safety of roxadustat for treatment of anemia in patients with non–dialysis-dependent CKD: Pooled results of three randomized clinical trials. Clin J Am Soc Nephrol 16: 1190–1200, 2021 - PMC - PubMed
-
- Shutov E, Sułowicz W, Esposito C, Tataradze A, Andric B, Reusch M, Valluri U, Dimkovic N: Roxadustat for the treatment of anemia in chronic kidney disease patients not on dialysis: A phase 3, randomized, double-blind, placebo-controlled study (ALPS) [published online ahead of print February 25, 2021]. Nephrol Dial Transplant - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical